Project Baseline Featured in New York Times Article

Project Baseline, a landmark study in human health, is the subject of a recent New York Times story.

The article highlights the massive reach of the study, which is recruiting 10,000 adults aiming to look at early warning signs (markers in blood, urine, and stool in healthy people, for example) that can help predict cancer risk.

The article emphasizes the unique aspects of Project Baseline, a joint project among Stanford, Duke, and Verily Life Sciences.  As the article states, “Many of the people joining the study are healthy adults, which differs from traditional medical trials that focus largely on people who are already ill. Another key difference is that the researchers are collecting a staggering amount of medical data on their subjects: analyzing their microbiomes, sequencing their genomes, subjecting them to a variety of scans and assessing their cognitive health.”

At Stanford, Project Baseline is led by Sam Gambhir, MD, PhD, Virginia and D.K. Ludwig professor for clinical investigation in cancer research, Kenneth Mahaffey, MD, a professor of cardiovascular medicine and director of the Stanford Center for Clinical Research (SCCR); and Rebecca McCue and Susan Spielman, who wear several hats in the School of Medicine.

Read more about the project here.